Medline Inc (MDLN) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Medline Inc   (NASDAQ: MDLN)
 

Medline Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Medline Inc 's inventory turnover ratio, the ratio that measures Medline Inc 's ability to manage its supply chain, sequentially decreased to 3.41 in the second quarter 2026, but it does not raise any concerns as Medline Inc continue to execute well, and the inventory turnover ratio remains above the average. Medline Inc 's average inventory processing period in the Jun 27 2026 quarter, has increased to 107 days, from 84 days, in the Mar 28 2026 quarter.

Within Healthcare sector Medline Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

MDLN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Medline Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDLN Inventory Turnover Ratio (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 28 2025)
II. Quarter		 (Mar 29 2025)
I. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth 13.49 % - - - -
Inventory Turnover Ratio (TTM) 3.41 4.36 - 8.8 -
MDLN's Total Ranking # # # # #
Average inventory processing period 107 84 - 41 -
Seq. Inventory Growth -2.95 % 0.8 % 7.02 % - -
Seq. Cost of Sales Growth -0.74 % - - 3.34 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



MDLN Company Profile >> Back to MDLN Efficiency Comparisons >> Compare MDLN Inventory Turnover Ratio to its Competitors

Financial Statements
Medline Inc 's Inventories $ 4,665 Millions Visit MDLN's Balance sheet
Medline Inc 's Cost of Revenues TTM $ 15,962 Millions Visit MDLN's Income Statement
What are MDLN's Sales? Visit MDLN's Sales by Segment

Other Inventory Turnover Ratios
Medline Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MDLN's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MDLN's Competitors
Inventory Turnover Ratio for MDLN's Suppliers
Inventory Turnover Ratio for MDLN's Customers

You may also want to know
MDLN's Sales Growth Rates MDLN's Pe Price to earnings ratio MDLN's Receivables Turnover Ratio MDLN's Stock Quote
MDLN's Net Income Growth Rates MDLN's Ps Price to Sales ratio MDLN's Sales per Employee MDLN's Asset Turnover Ratio
MDLN's Net Margin MDLN's Pb Price to Book ratio MDLN's Financial Strength Ratios MDLN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 27 2026 Inventories at quarter ending Jun 27 2026
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions

Date modified: 2026-09-08T15:11:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.